These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
220 related articles for article (PubMed ID: 26400542)
1. MicroRNAs mediate the cardioprotective effect of angiotensin-converting enzyme inhibition in acute kidney injury. Rana I; Velkoska E; Patel SK; Burrell LM; Charchar FJ Am J Physiol Renal Physiol; 2015 Dec; 309(11):F943-54. PubMed ID: 26400542 [TBL] [Abstract][Full Text] [Related]
2. Chronic kidney disease: cardiac and renal angiotensin-converting enzyme (ACE) 2 expression in rats after subtotal nephrectomy and the effect of ACE inhibition. Burrell LM; Burchill L; Dean RG; Griggs K; Patel SK; Velkoska E Exp Physiol; 2012 Apr; 97(4):477-85. PubMed ID: 22198016 [TBL] [Abstract][Full Text] [Related]
3. Adverse cardiac effects of exogenous angiotensin 1-7 in rats with subtotal nephrectomy are prevented by ACE inhibition. Burrell LM; Gayed D; Griggs K; Patel SK; Velkoska E PLoS One; 2017; 12(2):e0171975. PubMed ID: 28192475 [TBL] [Abstract][Full Text] [Related]
4. Acute kidney injury in the rat causes cardiac remodelling and increases angiotensin-converting enzyme 2 expression. Burchill L; Velkoska E; Dean RG; Lew RA; Smith AI; Levidiotis V; Burrell LM Exp Physiol; 2008 May; 93(5):622-30. PubMed ID: 18223026 [TBL] [Abstract][Full Text] [Related]
5. Apocynin Attenuates Cardiac Injury in Type 4 Cardiorenal Syndrome via Suppressing Cardiac Fibroblast Growth Factor-2 With Oxidative Stress Inhibition. Liu Y; Liu Y; Liu X; Chen J; Zhang K; Huang F; Wang JF; Tang W; Huang H J Am Heart Assoc; 2015 Jun; 4(7):. PubMed ID: 26109504 [TBL] [Abstract][Full Text] [Related]
6. Preservation of kidney function with combined inhibition of NADPH oxidase and angiotensin-converting enzyme in diabetic nephropathy. Thallas-Bonke V; Coughlan MT; Bach LA; Cooper ME; Forbes JM Am J Nephrol; 2010; 32(1):73-82. PubMed ID: 20551625 [TBL] [Abstract][Full Text] [Related]
7. Effects of ACE inhibition and bradykinin antagonism on cardiovascular changes in uremic rats. Amann K; Gassmann P; Buzello M; Orth SR; Törnig J; Gross ML; Magener A; Mall G; Ritz E Kidney Int; 2000 Jul; 58(1):153-61. PubMed ID: 10886560 [TBL] [Abstract][Full Text] [Related]
8. ACE inhibition promotes upregulation of endothelial progenitor cells and neoangiogenesis in cardiac pressure overload. Müller P; Kazakov A; Jagoda P; Semenov A; Böhm M; Laufs U Cardiovasc Res; 2009 Jul; 83(1):106-14. PubMed ID: 19380417 [TBL] [Abstract][Full Text] [Related]
9. Cardiomyocyte loss in experimental renal failure: prevention by ramipril. Amann K; Tyralla K; Gross ML; Schwarz U; Törnig J; Haas CS; Ritz E; Mall G Kidney Int; 2003 May; 63(5):1708-13. PubMed ID: 12675846 [TBL] [Abstract][Full Text] [Related]
10. Effects of endothelin receptor antagonism and angiotensin-converting enzyme inhibition on cardiac and renal remodeling in the rat. Willette RN; Minehart H; Ellison J; Simons T; Short B; Pullen M; Ohlstein EH; Nambi P J Cardiovasc Pharmacol; 1998; 31 Suppl 1():S277-83. PubMed ID: 9595459 [TBL] [Abstract][Full Text] [Related]
11. Renin-angiotensin inhibition reverses advanced cardiac remodeling in aging spontaneously hypertensive rats. Ito N; Ohishi M; Yamamoto K; Tatara Y; Shiota A; Hayashi N; Komai N; Yanagitani Y; Rakugi H; Ogihara T Am J Hypertens; 2007 Jul; 20(7):792-9. PubMed ID: 17586415 [TBL] [Abstract][Full Text] [Related]
12. Osteopontin expression in progressive renal injury in remnant kidney: role of angiotensin II. Yu XQ; Wu LL; Huang XR; Yang N; Gilbert RE; Cooper ME; Johnson RJ; Lai KN; Lan HY Kidney Int; 2000 Oct; 58(4):1469-80. PubMed ID: 11012882 [TBL] [Abstract][Full Text] [Related]
13. Epigenetic Therapy for the Treatment of Hypertension-Induced Cardiac Hypertrophy and Fibrosis. Watson CJ; Horgan S; Neary R; Glezeva N; Tea I; Corrigan N; McDonald K; Ledwidge M; Baugh J J Cardiovasc Pharmacol Ther; 2016 Jan; 21(1):127-37. PubMed ID: 26130616 [TBL] [Abstract][Full Text] [Related]
14. Combination renin-angiotensin system blockade and angiotensin-converting enzyme 2 in experimental myocardial infarction: implications for future therapeutic directions. Burchill LJ; Velkoska E; Dean RG; Griggs K; Patel SK; Burrell LM Clin Sci (Lond); 2012 Dec; 123(11):649-58. PubMed ID: 22715807 [TBL] [Abstract][Full Text] [Related]
15. Renin-angiotensin system blockade prevents the increase in plasma transforming growth factor beta 1, and reduces proteinuria and kidney hypertrophy in the streptozotocin-diabetic rat. Erman A; Veksler S; Gafter U; Boner G; Wittenberg C; van Dijk DJ J Renin Angiotensin Aldosterone Syst; 2004 Sep; 5(3):146-51. PubMed ID: 15526251 [TBL] [Abstract][Full Text] [Related]
16. Expression of transforming growth factor-beta1 and type IV collagen in the renal tubulointerstitium in experimental diabetes: effects of ACE inhibition. Gilbert RE; Cox A; Wu LL; Allen TJ; Hulthen UL; Jerums G; Cooper ME Diabetes; 1998 Mar; 47(3):414-22. PubMed ID: 9519748 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of ADP-ribosyl cyclase attenuates angiotensin II-induced cardiac hypertrophy. Gul R; Park JH; Kim SY; Jang KY; Chae JK; Ko JK; Kim UH Cardiovasc Res; 2009 Feb; 81(3):582-91. PubMed ID: 18719074 [TBL] [Abstract][Full Text] [Related]
19. Pathological expression of renin and angiotensin II in the renal tubule after subtotal nephrectomy. Implications for the pathogenesis of tubulointerstitial fibrosis. Gilbert RE; Wu LL; Kelly DJ; Cox A; Wilkinson-Berka JL; Johnston CI; Cooper ME Am J Pathol; 1999 Aug; 155(2):429-40. PubMed ID: 10433936 [TBL] [Abstract][Full Text] [Related]
20. Cardiovascular oxidative stress is reduced by an ACE inhibitor in a rat model of streptozotocin-induced diabetes. Fiordaliso F; Cuccovillo I; Bianchi R; Bai A; Doni M; Salio M; De Angelis N; Ghezzi P; Latini R; Masson S Life Sci; 2006 Jun; 79(2):121-9. PubMed ID: 16445948 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]